Lonza Group AG Company Profile | StatInvestor

Health Care & Life Sciences » Biotechnology | Lonza Group AG

Lonza Group AG

Lonza Group AG Zuerich Namen Akt
Stock Exchange	Other OTC
EPS	$7.68
Market Cap	$24.61 B
Shares Outstanding	74.47 M
Public Float	-

Lonza Group AG ADR
Stock Exchange	Other OTC
EPS	$0.77
Market Cap	$24.55 B
Shares Outstanding	744.69 M
Public Float	-

Lonza Group AG
Stock Exchange	SIX Swiss Exchange
EPS	CHF12.06
Market Cap	CHF23.26 B
Shares Outstanding	74.47 M
Public Float	74.16 M

Profile

Address	Muenchensteinerstrasse 38 Basel Basel-Stadt (Basle Town) 4002 Switzerland
Employees	-
Website	http://www.lonza.com
Updated	09/14/2018
Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the Pharma&Biotech and Specialty Ingredients segemnts. The Pharma&Biotech segment deals with the supply of pharmaceutical ingredients and biopharmaceuticals as well as research and testing products and services.

Financials

Albert M. Baehny

Chairman

Olivier Verscheure

Director